Clinical eligibility for hospice is a requirement to elect the Medicare Hospice Benefit and it ensures hospices are reimbursed for care. Each disease state has specific eligibility guidelines that should be met before admission to hospice. This course focuses on the clinical eligibility for neurological diseases common at the end of life including ALS, Alzheimer's disease, stroke, and coma. For each disease state, you will learn the pathophysiology, at least one staging scale, specific Local Coverage Determination (LCD) guidelines for eligibility, and appropriate documentation to support eligibility. The goal of this course is to provide nurses in hospice and palliative care with knowledge of hospice clinical eligibility for neurological diseases.
Clinical eligibility for hospice is a requirement to elect the Medicare Hospice Benefit and it ensures hospices are reimbursed for care. Each disease state has specific eligibility guidelines that should be met before admission to hospice. This course focuses on the clinical eligibility for neurological diseases common at the end of life including ALS, Alzheimer's disease, stroke, and coma. For each disease state, you will learn the pathophysiology, at least one staging scale, specific Local Coverage Determination (LCD) guidelines for eligibility, and appropriate documentation to support eligibility. The goal of this course is to provide nurses in hospice and palliative care with knowledge of hospice clinical eligibility for neurological diseases.
Provider approved by the California Board of Registered Nursing, CEP# 13791
Nurses will receive 1.00 contact hours for participating in this course.
District of Columbia Board of Nursing Approved Continuing Education program (CEBroker Provider #50-290).
Florida Board of Nursing (CEBroker Provider #50-290)
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Georgia Board of Nursing (CEBroker Provider #50-290)
South Carolina Board of Nursing (CEBroker Provider #50-290)
West Virginia Board of Registered Nursing (CEBroker Provider #50-290)
New Mexico Board of Nursing (CEBroker Provider #50-290)
Arkansas State Board Of Nursing Approved Continuing Education program (CEBroker Provider #50-290).
Kentucky Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.00 contact hours for participating in this course.
Mississippi Board of Nursing (CEBroker Provider #50-290)
North Dakota Board of Nursing (CEBroker Provider #50-290)
Outline:
Make the System Work for Your Patients
Section 3: Amyotrophic Lateral Sclerosis
Section 4: Alzheimer’s Disease
Susan Heinzerling earned a Bachelor of Science in biology and a Bachelor of Science in nursing from the University of North Carolina at Chapel Hill as well as a Master of Life Sciences in physiology from North Carolina State University. She became a doctoral candidate in immunology at the University of South Alabama. Her research experiences in the biomedical sciences led to an interest in evidence-based practices. Ms. Heinzerling began her nursing career as a medical/surgical nurse. Renal patients in acute care with multiple chronic conditions and repeated hospitalizations inspired her practice of hospice nursing. She has worked as a hospice admissions nurse and a hospice RN case manager in both a large urban setting and a rural community. Disclosure: Susan Heinzerling, BSN, RN, CHPN has no Relevant Financial or Non-Financial Relationship with ineligible companies to disclose.
Access to over 1,450 courses! Access to 1,450+ courses for one low price.